Investors are showing strong interest in the Cell Point (India) IPO, with the initial share sale having been subscribed 2.3 times so far. The IPO is a fresh equity issue of up to 50.34 lakh equity shares at Rs 100 per share, with no offer for sale in the public offering. The net proceeds will go towards repayment of some debt, store repairs and setting up new retail stores. Meanwhile, the Aatmaj IPO had a slow start, with just 16% of shares subscribed so far, and the Vilin Bio IPO has been subscribed 50% so far, while the Cosmic CRF IPO is subscribed 75%.